ALXO (ALX Oncology Holdings Inc.) Stock Market Reviews

crown

search

Read and share opinions on ALXO (ALX Oncology Holdings Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock mark

ALXO

ALX Oncology Holdings Inc.

clarify Biotechnology

bookmark Healthcare

public United States

Sell Neutral Buy

Latest News

ALX Oncology Holdings Inc (ALXO) Q3 2025 Earnings Call Highlights: Promising Clinical Advances ...
Nov 8, 2025
ALX Oncology to Report Third Quarter 2025 Financial Results and Pipeline Progress Including Evorpacept CD47 Biomarker Data to be Presented at Upcoming SITC Annual Meeting
Oct 30, 2025
Is Alnylam Pharmaceuticals (ALNY) Outperforming Other Medical Stocks This Year?
Oct 14, 2025
ALX Oncology to Present Updated Data from Phase 2 ASPEN-06 Trial, Highlighting CD47 Expression as a Predictive Biomarker in HER2+ Gastric Cancer, at 40th Society for Immunotherapy of Cancer (SITC) Annual Meeting
Oct 3, 2025
CEO & Director of ALX Oncology Holdings Picks Up 69% More Stock
Sep 21, 2025
ALX Oncology to Participate in Upcoming Investor Conferences in September
Aug 29, 2025
ALX Oncology Holdings Inc (ALXO) Q2 2025 Earnings Call Highlights: Promising Trial Results and ...
Aug 13, 2025
ALX Oncology to Report Second Quarter 2025 Financial Results on August 12, 2025
Aug 5, 2025
ALX Oncology to Present at the Jefferies 2025 Global Healthcare Conference
May 30, 2025
ALX Oncology to Host R&D Webcast Event Highlighting its Novel EGFR Targeting Antibody-Drug Conjugate, ALX2004, on May 20, 2025
May 13, 2025
ALX Oncology to Report First Quarter 2025 Financial Results on May 8, 2025
May 2, 2025

Reviews